Blacks and Hispanics have higher inpatient use for mycosis fungoides
April 15, 2021
Findings reinforce need to maintain “higher index of suspicion” in these patients.
COVID-19’s impact on lupus inpatients examined in study
March 24, 2021
Younger inpatients with COVID-19 and SLE showed higher mortality than did COVID-19 inpatients of similar age from the general population in a French epidemiologic study.
Even a few days of steroids may be risky, new study suggests
July 9, 2020
A retrospective study of more than 2.6 million Taiwanese adults echoes findings from a 2017 cohort study of more than 1.5 million U.S. adults.
Dermatologic changes with COVID-19: What we know and don’t know
May 18, 2020
Two dermatologists discuss “COVID toes” and other apparent dermatologic manifestations of COVID-19.
Case reports illustrate heterogeneity of skin manifestations in COVID patients
May 5, 2020
Any health professional is invited to submit cases of COVID-19–associated dermatoses to a registry set up by the American Academy of Dermatology.
COVID-19 PPE-related skin effects described in survey of Chinese doctors, nurses
April 16, 2020
Almost 75% of doctors and nurses in and around Wuhan, China, reported skin problems during a single week in early February.
Skin manifestations are emerging in the coronavirus pandemic
April 3, 2020
“COVID-19 can feature signs of small blood vessel occlusion. These can be petechiae or tiny bruises, and transient lividoid eruptions.”
By the numbers: Readmissions for skin conditions
May 24, 2019
The 5-year analysis shows rates are highest for vascular hamartomas, dermatomyositis, and mycosis fungoides.
FDA approves omadacycline for pneumonia and skin infections
October 4, 2018
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.